Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease

NCT00003913 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

390

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Lymphoma
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Diseases

Interventions

BIOLOGICAL: anti-thymocyte globulin
BIOLOGICAL: filgrastim
DRUG: busulfan
DRUG: cyclophosphamide
DRUG: methylprednisolone
PROCEDURE: umbilical cord blood transplantation
RADIATION: radiation therapy

Sponsor

Fred Hutchinson Cancer Center

Collaborators

[object Object]
[object Object]